Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-12-22

Clinical Trial Update: L-Arginine in Pre-Eclampsia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating L-Arginine for preeclampsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Pre-Eclampsia | Phase 3 | Status: COMPLETED